Table 5.
Studies on ablation therapy for liver metastasis from Pancreatic ductal adenocarcinoma
| Author | Publication year | Type of ablation | No. of patients | No. of tumors | Size of tumors [mm] | Follow-up [months] | Local tumor control [%] | Overall survival [months] | Overall survival [%] (Progression-free survival [%]) |
||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-year | 2-year | 3-year | 4-year | 5-year | |||||||||
| Du et al. [37] | 2022 | RFA | 20 | 29 | 26 (mean) | – | 85 | 14.6 (mean) | 39.5 (26.0) | 18.1 (17.3) | – | – | – |
| Yan et al. [38] | 2021 | RFA/MWA | 74 | – | – | 27.8 (median) | – | 10.8 (median) | 81.1 | 67.6 | 52.6 | – | – |
RFA radiofrequency ablation, MWA microwave ablation